David M Albala
Overview
Explore the profile of David M Albala including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
121
Citations
1727
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dowling R, Zhang S, Goldfischer E, Albala D, Bart A
Urol Pract
. 2024 Feb;
11(3):474-485.
PMID: 38324307
Introduction: The acute phase of the COVID-19 pandemic disrupted ambulatory care in the US, and in response telemedicine was adopted rapidly but unevenly across specialties and time. This study examines...
2.
3.
4.
Dowling R, Chen Q, Goldfischer E, Albala D
Urol Pract
. 2023 May;
10(4):309-310.
PMID: 37155949
No abstract available.
5.
Dowling R, Chen Q, Goldfischer E, Albala D
Urol Pract
. 2023 Apr;
10(4):301-309.
PMID: 37103884
Introduction: The Renal or Ureteral Stone Surgical Treatment Episode-based Measure in the Quality Payment Program evaluates clinicians' cost to Medicare for beneficiaries who receive surgical treatment for stones. The measure...
6.
Bart A, Van Hoof A, Badre-Hume R, Selvarajah J, Robillard K, Albala D
Curr Opin Urol
. 2022 Sep;
32(6):598-606.
PMID: 36081393
Purpose Of Review: The benefits of testosterone therapy (TTh) in the hypogonadal male can be dramatic. Historically, TTh has been contraindicated in prostate cancer (PCa). Current evidence has redefined our...
7.
Beale R, Sicilila S, Riestra P, Albala D
Curr Opin Urol
. 2021 Nov;
32(1):109-115.
PMID: 34798638
Purpose Of Review: Robotic pyeloplasty is still a relatively novel procedure. Clinically, early studies have shown high success rates, decreased complication rates, decreased length of hospital stay, and better cosmetic...
8.
Varsanik J, Manak M, Whitfield M, Hogan B, Su W, Jiang C, et al.
Rev Urol
. 2021 Apr;
22(4):159-167.
PMID: 33927573
To the usefulness and applications of machine vision (MV) and machine learning (ML) techniques that have been used to develop a single cell-based phenotypic (live and fixed biomarkers) platform that...
9.
Shore N, Antonarakis E, Cookson M, Crawford E, Morgans A, Albala D, et al.
Prostate
. 2020 Mar;
80(6):527-544.
PMID: 32130741
Background: For specific clinical indications, androgen deprivation therapy (ADT) will induce disease prostate cancer (PC) regression, relieve symptoms and prolong survival; however, ADT has a well-described range of side effects,...
10.
Manak M, Varsanik J, Hogan B, Whitfield M, Su W, Joshi N, et al.
Nat Biomed Eng
. 2019 Mar;
2(10):761-772.
PMID: 30854249
The risk stratification of prostate cancer and breast cancer tumours from patients relies on histopathology, selective genomic testing, or on other methods employing fixed formalin tissue samples. However, static biomarker...